In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...

Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.

The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...